Vimarsana
Biggest News Aggregation in the World

Page 2 - Aldosterone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldosterone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldosterone Today - Breaking & Trending Today

Hormones and high blood pressure: Study reveals endocrine culprits and targeted treatments - Vimarsana News

Hormones and high blood pressure: Study reveals endocrine culprits and targeted treatments

Researchers delve into endocrine causes of hypertension (HTN), revealing key culprits like primary aldosteronism and Cushing's syndrome. The study also evaluates the efficacy of various treatments, offering valuable insights for tackling this widespread health issue.

Insomnia's toll on the heart: study highlights cardiovascular event risks - Vimarsana News

Insomnia's toll on the heart: study highlights cardiovascular event risks

Researchers performed a meta-analysis to evaluate the incidence of cardiovascular (CV) events among individuals with insomnia.

Lorundrostat Shows Promise in Phase 2 Trial for Uncontrolled, Resistant Hypertension - Vimarsana News

Lorundrostat Shows Promise in Phase 2 Trial for Uncontrolled, Resistant Hypertension

New data from a dose-finding trial suggests the aldosterone synthase inhibitor lorundrostat could find a role in the management of resistant or uncontrolled hypertension.

Vagus nerve stimulation shows mixed results in lowering stress hormone aldosterone - Vimarsana News

Vagus nerve stimulation shows mixed results in lowering stress hormone aldosterone

The study explored the effects of acute transcutaneous vagus nerve stimulation (tVNS) on serum aldosterone levels in both younger and older adults. While active tVNS did lead to a reduction in aldosterone levels, the changes were not significantly different from those observed in sham treatments, with aldosterone levels also varying based on age and sex.

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes - Vimarsana News

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.